- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04666857
Family Centred Early Intervention of Infants With Congenital Heart Disease
Family Centred Early Intervention to Improve Motor Development of Infants With Severe Congenital Heart Disease
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
In this feasibility pilot randomised study children will be randomly assigned to a control and an intervention group. Children of the control group will receive standard of care for infants with severe CHD: cardiac surveillance, counselling and screening at the University Children's Hospital Zurich and standardised developmental checkups by their paediatrician. Physiotherapy is normally not comprised in standard of care, but some infants may receive physiotherapy, if they present with obvious signs of motor developmental delay, detected by the paediatrician later on in their life. Once enrolled in this study, an infant of the control group will not receive early motor intervention as an infant enrolled in the intervention group.
Infants randomly assigned to the intervention group will receive early motor intervention, which will be based on the results of our qualitative study. It will comprise supporting parents by a paediatric physiotherapist. Parents will be guided on how to best stimulate their infant's development during daily activities. Parents will be actively involved in the intervention with the aim to challenge their infant at the limit of its postural capacity and thus help the infant to optimize its motor repertoire. The intervention will start after baseline with infants aged 3-6 months and end after three months with infants aged 6-9 months.
The intervention will start at home, then alternating at the Children's Hospital and at home. Telephone or video counselling will be provided to support parents if needed. The order may change according to the needs of the family when necessary and adjusted to best fit the daily routine the family.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Zürich, Switzerland, 8032
- University Children's Hospital
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Infants born with severe cyanotic and acyanotic congenital heart disease (e.g. tetralogy of Fallot, pulmonary atresia, transposition of the great arteries, atrial/ventricular septal defects, double outlet right ventricle, ...) who undergo open-heart surgery once before the first 3-6 months of their life
- Parents able to comprehend the patient information linguistically and cognitively
- Informed consent of parents as documented by signature
Exclusion Criteria:
- Infants with hypoplastic left heart syndrome as they need to undergo several open-heart surgeries within the first period of their life.
- Infants with trisomy 21 and other syndromes like 22q11 microdeletion syndrome, CHARGE syndrome that are often associated with CHD. These infants often show additional cognitive impairments that might confound the effect of our intervention.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
No Intervention: standard care
Control subject will receive standard care of treatment
|
|
|
Experimental: intervention group
intervention group will receive early intervention
|
infants with CHD after open heart surgery will receive early intervention
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Dropout rate
Time Frame: "3 up to 6 months of age" (baseline) and at "12 months of age"
|
The primary outcome will test the procedure for its acceptability, estimation the likely rates of recruitment and retention of subjects and the calculation of appropriate sample size.
Further objectives are the usefulness of the outcome assessment measures.
|
"3 up to 6 months of age" (baseline) and at "12 months of age"
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Hammersmith Infant Neurological Examination
Time Frame: "3 up to 6 months of age" (baseline) and at "12 months of age"
|
The Hammersmith Infant Neurological Examination assesses different aspects of neurological function. the higher the scores the better, the range depends on the child's abilities metric: ordinal |
"3 up to 6 months of age" (baseline) and at "12 months of age"
|
|
General Movements
Time Frame: "3 up to 6 months of age" (baseline)
|
The General Movement assessment is a video-based, non-invasive way to identify neurological deviations that may lead to neurodevelopmental disorders later in life. The more variables the motor output of infants, the better infants' neuromotor development will be. metric: categorial |
"3 up to 6 months of age" (baseline)
|
|
Infant Motor Profile
Time Frame: "3 up to 6 months of age" (baseline), "6 up to 9 months of age" (end of intervention), at "12 months of age"
|
The Infant Motor Profile is a standardised and qualitative method to assess motor behaviour in infants, a 15 minutes, video-based assessment tool, consists of 5 domains: motor variation, adaptability, symmetry, fluency and performance. The higher the score, the better - the range depends on the child's abilities and is age dependent metric: ordinal |
"3 up to 6 months of age" (baseline), "6 up to 9 months of age" (end of intervention), at "12 months of age"
|
|
Alberta Infant Motor Scale Change in being assessed at different time points at baseline, at the end of the intervention after three months and at follow up
Time Frame: "3 up to 6 months of age" (baseline), "6 up to 9 months of age" (end of intervention) and at "12 months of age"
|
The Alberta Infant Motor Scale is an observational measure of infants' gross motor development from birth until 18 months consisting of 58 items, measuring infants' performance; The higher the score, the better, the range depends on the child's abilities and is age dependent metric: ordinal |
"3 up to 6 months of age" (baseline), "6 up to 9 months of age" (end of intervention) and at "12 months of age"
|
|
Bayley Scale for Infant and Toddlers Development
Time Frame: "around 12 months of age"
|
Bayley Scale for Infant and Toddlers Development is an internationally used and validated battery to assesses key domains of cognition, language, socio-emotional, motor and adaptive behaviour by standardized observation and rating of the play behaviour of children the higher the scores the better, the range depends on the child's abilities and is age dependent metric: ordinal
|
"around 12 months of age"
|
|
Parental Stress Index
Time Frame: "3 up to 6 months of age" (baseline), "6 up to 9 months of age" (end of intervention) and at "12 months of age"
|
The Parental Stress Index investigates parental stress of children with all different kind of diagnoses, consists of 5 subscales assessing areas where parental strain is high; the Parental Stress Index consists of 48 items the lower, the score the better metric: ordinal |
"3 up to 6 months of age" (baseline), "6 up to 9 months of age" (end of intervention) and at "12 months of age"
|
|
Brief Symptom Inventory 18
Time Frame: "3 up to 6 months of age" (baseline), "6 up to 9 months of age" (end of intervention) and at "12 months of age"
|
The Brief Symptom Inventory 18 contains a three six-item scales somatization, depression, and anxiety as well as the Global Severity Index the lower, the score the better metric: ordinal |
"3 up to 6 months of age" (baseline), "6 up to 9 months of age" (end of intervention) and at "12 months of age"
|
|
Parental Overprotection Measure
Time Frame: "3 up to 6 months of age" (baseline), "6 up to 9 months of age" (end of intervention) and at "12 months of age"
|
The Parental Overprotection Measure assesses parenting behaviours that restrict a child's exposure to situations containing perceived threat or harm. the higher the scores the more parents protect their children metric: ordinal |
"3 up to 6 months of age" (baseline), "6 up to 9 months of age" (end of intervention) and at "12 months of age"
|
|
Family Empowerment Scale
Time Frame: "3 up to 6 months of age" (baseline), "6 up to 9 months of age" (end of intervention) and at "12 months of age"
|
The Family Empowerment Scale measures empowerment of families. It consists of three subscales, family, service system and community/political. We use the subscale family to gather relevant information as a result of an intervention. the higher the scores the more the family feels empowered metric: ordinal |
"3 up to 6 months of age" (baseline), "6 up to 9 months of age" (end of intervention) and at "12 months of age"
|
|
Quality of life form Short Form 36
Time Frame: "3 up to 6 months of age" (baseline), "6 up to 9 months of age" (end of intervention) and at "12 months of age"
|
The Quality of life form Short Form 36 is a widely used questionnaire assessing self-reported health related quality of life the lower the score the better metric: ordinal |
"3 up to 6 months of age" (baseline), "6 up to 9 months of age" (end of intervention) and at "12 months of age"
|
|
Pediatric Quality of Life Inventory
Time Frame: "3 up to 6 months of age" (baseline), "6 up to 9 months of age" (end of intervention) and at "12 months of age"
|
The Pediatric Quality of Life Inventory measures quality of life of infants aged 1- 24 months. the higher the scores the more the quality of life is affected. metric: ordinal |
"3 up to 6 months of age" (baseline), "6 up to 9 months of age" (end of intervention) and at "12 months of age"
|
Collaborators and Investigators
Investigators
- Study Director: Bea Latal, Dr. med., University Children's hospital, Zürich
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- EMI
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Congenital Heart Disease in Children
-
The Children's Hospital of Zhejiang University...Beijing Children's Hospital; Children's Hospital of Nanjing Medical UniversityNot yet recruitingCongenital Heart Disease in Children | Congenital Heart Disease (CHD)China
-
Children's Mercy Hospital Kansas CityChildren's Hospital of Philadelphia; National Heart, Lung, and Blood Institute... and other collaboratorsRecruitingCongenital Heart Disease in ChildrenUnited States
-
Instituto de Cardiologia do Rio Grande do SulIrmandade Santa Casa de Misericórdia de Porto AlegreCompletedCongenital Heart Disease | Deglutition Disorders in ChildrenBrazil
-
University Hospital, Strasbourg, FranceRecruitingCongenital Heart Disease in ChildrenFrance
-
Charles University, Czech RepublicEnrolling by invitationCongenital Heart Disease in ChildrenCzechia
-
Boston Children's HospitalThe Hospital for Sick Children; Baylor College of Medicine; Children's Hospital... and other collaboratorsRecruitingCongenital Heart Disease in ChildrenUnited States, Canada
-
University Hospital, Strasbourg, FranceCompletedCongenital Heart Disease in ChildrenFrance
-
Stanford UniversityNational Institutes of Health (NIH)Not yet recruitingCongenital Heart Disease in Children
-
Assiut UniversityNot yet recruitingCommon Cases in Pediatric Intensive Care in Assuit University Cardiology Institute, a Clinical AuditCongenital Heart Disease in Children
-
Xinhua Hospital, Shanghai Jiao Tong University...RecruitingCongenital Heart Disease in ChildrenChina
Clinical Trials on early motor intervention
-
Duquesne UniversityUniversity of Washington; Virginia Commonwealth University; University of Delaware and other collaboratorsCompletedCerebral Palsy | Developmental Delay | Infant DevelopmentUnited States
-
University of ThessalyActive, not recruitingPremature Birth | Parenting | Neonatal DiseaseGreece
-
National Taiwan University HospitalCompletedSubarachnoid Aneurysm HemorrhageTaiwan
-
Elcin AkyurekNot yet recruiting
-
Liverpool School of Tropical MedicineUniversity of Warwick; Ministry of Health and Population, Malawi; Research for... and other collaboratorsCompleted
-
National Taiwan University HospitalCompleted
-
National Taiwan University HospitalRecruitingSubarachnoid Aneurysm HemorrhageTaiwan
-
Georgia State UniversityEunice Kennedy Shriver National Institute of Child Health and Human Development...Completed
-
Oregon Health and Science UniversityNational Institute of Mental Health (NIMH); University of Connecticut; University... and other collaboratorsNot yet recruiting
-
University of RochesterAmerican Cancer Society, Inc.Completed